Apollo Medical (NASDAQ:AMEH – Get Free Report) was upgraded by analysts at Bank of America from a “neutral” rating to a “buy” rating in a research note issued on Thursday, Marketbeat reports. The firm presently has a $55.00 price objective on the stock, up from their previous price objective of $44.00. Bank of America‘s price […]
Apollo Medical (NASDAQ:AMEH – Get Free Report) issued an update on its FY 2023 earnings guidance on Tuesday morning. The company provided EPS guidance of 1.100-1.200 for the period, compared to the consensus EPS estimate of 1.200. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion. […]
Analysts at Stifel Nicolaus began coverage on shares of Apollo Medical (NASDAQ:AMEH – Get Free Report) in a research report issued on Wednesday, Marketbeat reports. The brokerage set a “buy” rating and a $45.00 price target on the stock. Stifel Nicolaus’ price target points to a potential upside of 26.87% from the stock’s current price. […]
Apollo Medical (NASDAQ:AMEH – Get Free Report) updated its FY 2023 earnings guidance on Monday. The company provided earnings per share guidance of 1.100-1.200 for the period, compared to the consensus earnings per share estimate of 1.190. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion. […]
Apollo Medical (NASDAQ:AMEH – Get Free Report) and Abri SPAC I (NASDAQ:ASPA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations. Profitability This table compares Apollo Medical […]